Sign in to continue:

Friday, March 6th, 2026

Zhenro Properties Group Announces February 2026 Unaudited Sales Statistics and Cautions Investors 1

Zhenro Properties Group Limited Announces Unaudited Operating Statistics for February 2026

Zhenro Properties Group Limited (Stock Code: 6158) has released its unaudited operating statistics for February 2026, providing investors with a snapshot of its latest sales performance. The announcement, dated 5 March 2026, was made by Chairman Chan King Tak and is intended to support transparency and inform shareholders and market participants on the company’s financial health and business momentum.

Key Highlights

  • February 2026 Contracted Sales:
    The Group, including its joint ventures and associated companies, achieved aggregated contracted sales of approximately RMB303 million.
  • Gross Floor Area Sold:
    The contracted gross floor area sold in February totaled around 19,146 square meters.
  • Average Selling Price:
    The contracted average selling price for the month was about RMB15,800 per square meter.
  • Year-to-date Performance (January-February 2026):
    Aggregated contracted sales reached RMB649 million over the first two months of 2026.
  • Total Gross Floor Area Sold for Two Months:
    Approximately 47,064 square meters sold.
  • Average Selling Price for Two Months:
    Approximately RMB13,800 per square meter.

Important Shareholder Information & Potential Price Sensitivity

  • Unaudited Figures: The operating statistics disclosed are unaudited and based on preliminary internal information. There may be discrepancies when compared to the audited or unaudited consolidated financial statements to be published by the Company annually or half-yearly. This could impact investor confidence and potentially affect share price volatility.
  • Cautionary Statement: Investors are explicitly advised to exercise caution and not place undue reliance on the unaudited data. The company warns that uncertainties in the collation process may result in differences from future official financial disclosures.
  • Professional Advice Recommended: When uncertain, investors should seek advice from licensed securities dealers, registered institutions in securities, bank managers, solicitors, certified public accountants, or other professional advisers.
  • Board Composition: Current board members include:

    • Executive Directors: Mr Chan King Tak, Mr Jin Mingjie
    • Non-Executive Director: Mr Chow Wai Shing Daniel
    • Independent Non-Executive Directors: Mr Wang Chuanxu, Mr Xie Jun, Ms Yang Yongyi

    This information may be relevant for governance and oversight considerations.

Detailed Analysis

The reported sales figures indicate Zhenro Properties Group Limited is maintaining a steady sales pace in early 2026. The February sales volume and average selling price are notably higher compared to the two-month average, suggesting possible improvement in pricing or product mix. However, the reliance on unaudited data adds an element of uncertainty, which could be price sensitive especially if the final audited numbers diverge significantly from these preliminary figures.

Investors should closely monitor future official announcements, as any material deviation in financial results may influence the Company’s share value. The company’s explicit warning to not place undue reliance on these figures underscores the importance of due diligence and risk management for shareholders.

Disclaimer

This article is based on unaudited preliminary internal information released by Zhenro Properties Group Limited. The reported figures may differ from future audited financial statements. Investors are advised to exercise caution, consult professional advisers, and not make investment decisions solely based on this information. The author and publisher disclaim any liability for actions taken based on this report.

View ZHENRO PPT Historical chart here



Simcere Pharmaceutical Issues Profit Alert: FY2025 Revenue and Profit Expected to Surge on Innovative Pharma Growth 12

Simcere Pharmaceutical Issues Significant Profit Alert for FY2025 Simcere Pharmaceutical Group Issues Substantial Profit Alert for FY2025: Major Growth Expected Simcere Pharmaceutical Group Limited (Stock code: 2096) has released an important profit alert, signalling...

Maoyan Entertainment Expects 197%-224% Profit Surge in 2025 with Record Revenue Growth and Box Office Success

Maoyan Entertainment Issues Positive Profit Alert for FY2025: Significant Revenue and Profit Growth Expected Key Highlights from the Announcement Substantial Revenue Growth: Maoyan Entertainment expects its revenue for the financial year ended December 31,...

BlackRock Disclosure of Share Dealings in ENN Energy Holdings Ltd – Privatisation Scheme Update (Feb 2026) 1

BlackRock Disclosure of Dealings in ENN Energy Holdings Ltd Shares Significant Share Transactions by BlackRock in ENN Energy Holdings Ltd Amid Privatisation Scheme Key Highlights Date of Disclosure: 27 February 2026 Context: Privatisation of...

   Ad